KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Total Non-Current Liabilities (2016 - 2025)

Pacira BioSciences has reported Total Non-Current Liabilities over the past 16 years, most recently at $551.2 million for Q4 2025.

  • Quarterly results put Total Non-Current Liabilities at $551.2 million for Q4 2025, down 26.98% from a year ago — trailing twelve months through Dec 2025 was $551.2 million (down 26.98% YoY), and the annual figure for FY2025 was $551.2 million, down 26.98%.
  • Total Non-Current Liabilities for Q4 2025 was $551.2 million at Pacira BioSciences, up from $545.1 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for PCRX hit a ceiling of $1.3 billion in Q4 2021 and a floor of $545.1 million in Q3 2025.
  • Median Total Non-Current Liabilities over the past 5 years was $737.8 million (2023), compared with a mean of $774.9 million.
  • Biggest five-year swings in Total Non-Current Liabilities: surged 100.77% in 2021 and later crashed 38.9% in 2023.
  • Pacira BioSciences' Total Non-Current Liabilities stood at $1.3 billion in 2021, then crashed by 30.36% to $896.5 million in 2022, then decreased by 22.96% to $690.7 million in 2023, then rose by 9.3% to $754.9 million in 2024, then decreased by 26.98% to $551.2 million in 2025.
  • The last three reported values for Total Non-Current Liabilities were $551.2 million (Q4 2025), $545.1 million (Q3 2025), and $754.3 million (Q2 2025) per Business Quant data.